Trevi Therapeutics, Inc. TRVI
14.33 USD +1.52 (+11.87%)
At closeNov 6, 2026, 6:15 PM EST
14.90 +0.57 +3.98%
After hours · Nov 6, 6:15 PM ET
13.00 Day range 14.36
9.99 52-week range 19.50
- YTD
- +14.46%
- 1 year
- +30.15%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -49.33M | -51.52M | -33.92M | -29.91M | -32.48M | |
| -42.76M | -47.91M | -29.07M | -29.15M | -33.94M | |
| -0.32 | -0.47 | -0.29 | -0.45 | -1.49 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 18.91M | 34.10M | 32.40M | 12.59M | 36.83M | |
| 193.44M | 110.90M | 89.40M | 123.02M | 38.48M | |
| 10.20M | 11.26M | 6.86M | 15.56M | 21.40M | |
| 753.00K | 1.03M | 1.34M | 9.18M | 14.74M | |
| 183.24M | 99.64M | 82.55M | 107.46M | 17.07M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -42.09M | -38.26M | -31.71M | -28.18M | -28.95M | |
| -94.11M | -21.53M | 59.43M | -107.37M | 0 | |
| 121.01M | 61.48M | -7.91M | 111.31M | 20.77M | |
| -12.00K | -35.00K | -137.00K | -159.00K | 0 | |
| -15.18M | 1.70M | 19.81M | -24.24M | -8.17M |